特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效观察
目的:探讨特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效.方法:收治慢阻肺急性加重期患者40例,随机分为对照组和观察组.对照组采用异丙托溴铵、普米克令舒治疗,观察组采用特布他林、异丙托溴铵、普米克令舒联合雾化吸入治疗,比较两组治疗效果.结果:观察组有效率高于对照组,症状缓解时间少于对照组(P...
Gespeichert in:
| Veröffentlicht in: | 中国社区医师 2018, Vol.34 (32), p.53-54 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | chi |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 54 |
|---|---|
| container_issue | 32 |
| container_start_page | 53 |
| container_title | 中国社区医师 |
| container_volume | 34 |
| creator | 张凤秋 |
| description | 目的:探讨特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效.方法:收治慢阻肺急性加重期患者40例,随机分为对照组和观察组.对照组采用异丙托溴铵、普米克令舒治疗,观察组采用特布他林、异丙托溴铵、普米克令舒联合雾化吸入治疗,比较两组治疗效果.结果:观察组有效率高于对照组,症状缓解时间少于对照组(P |
| doi_str_mv | 10.3969/j.issn.1007-614x.2018.32.032 |
| format | Article |
| fullrecord | <record><control><sourceid>wanfang_jour</sourceid><recordid>TN_cdi_wanfang_journals_zgsqys201832032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>zgsqys201832032</wanfj_id><sourcerecordid>zgsqys201832032</sourcerecordid><originalsourceid>FETCH-wanfang_journals_zgsqys2018320323</originalsourceid><addsrcrecordid>eNpjYFAxNNAztjSz1M_SyywuztMzNDAw1zUzNKnQMzIwtNAzNtIzMDZiYeCEiUdwMPAWF2cmGRgYmZlZGBkZcDI0Pu_c-XRH85Pd057Nm_5y9r6nPdOebdv0uKHx6Z6mJztmPuuc8WzXlpeTtyJLPZu57vnGzU9bu5_sXvKiY9KLxilPJ3RAFDydsONp69Jnm3Y_nzb9WeuilzN2v2ja9axh6bOG5U-7Frxs7302Z_7zWS0g2akdL5Y3PV0_n4eBNS0xpziVF0pzM6i7uYY4e-iWJ-alJealx2fllxblAWXiq9KLCyuLQV4zNgJ6zJh4lQAUVIj9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效观察</title><source>Alma/SFX Local Collection</source><creator>张凤秋</creator><creatorcontrib>张凤秋</creatorcontrib><description>目的:探讨特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效.方法:收治慢阻肺急性加重期患者40例,随机分为对照组和观察组.对照组采用异丙托溴铵、普米克令舒治疗,观察组采用特布他林、异丙托溴铵、普米克令舒联合雾化吸入治疗,比较两组治疗效果.结果:观察组有效率高于对照组,症状缓解时间少于对照组(P<0.05).结论:特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效显著.</description><identifier>ISSN: 1007-614X</identifier><identifier>DOI: 10.3969/j.issn.1007-614x.2018.32.032</identifier><language>chi</language><publisher>223700,江苏省宿迁市泗阳康达医院呼吸科</publisher><ispartof>中国社区医师, 2018, Vol.34 (32), p.53-54</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/zgsqys/zgsqys.jpg</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>张凤秋</creatorcontrib><title>特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效观察</title><title>中国社区医师</title><description>目的:探讨特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效.方法:收治慢阻肺急性加重期患者40例,随机分为对照组和观察组.对照组采用异丙托溴铵、普米克令舒治疗,观察组采用特布他林、异丙托溴铵、普米克令舒联合雾化吸入治疗,比较两组治疗效果.结果:观察组有效率高于对照组,症状缓解时间少于对照组(P<0.05).结论:特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效显著.</description><issn>1007-614X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpjYFAxNNAztjSz1M_SyywuztMzNDAw1zUzNKnQMzIwtNAzNtIzMDZiYeCEiUdwMPAWF2cmGRgYmZlZGBkZcDI0Pu_c-XRH85Pd057Nm_5y9r6nPdOebdv0uKHx6Z6mJztmPuuc8WzXlpeTtyJLPZu57vnGzU9bu5_sXvKiY9KLxilPJ3RAFDydsONp69Jnm3Y_nzb9WeuilzN2v2ja9axh6bOG5U-7Frxs7302Z_7zWS0g2akdL5Y3PV0_n4eBNS0xpziVF0pzM6i7uYY4e-iWJ-alJealx2fllxblAWXiq9KLCyuLQV4zNgJ6zJh4lQAUVIj9</recordid><startdate>2018</startdate><enddate>2018</enddate><creator>张凤秋</creator><general>223700,江苏省宿迁市泗阳康达医院呼吸科</general><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2018</creationdate><title>特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效观察</title><author>张凤秋</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-wanfang_journals_zgsqys2018320323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2018</creationdate><toplevel>online_resources</toplevel><creatorcontrib>张凤秋</creatorcontrib><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>中国社区医师</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>张凤秋</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效观察</atitle><jtitle>中国社区医师</jtitle><date>2018</date><risdate>2018</risdate><volume>34</volume><issue>32</issue><spage>53</spage><epage>54</epage><pages>53-54</pages><issn>1007-614X</issn><abstract>目的:探讨特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效.方法:收治慢阻肺急性加重期患者40例,随机分为对照组和观察组.对照组采用异丙托溴铵、普米克令舒治疗,观察组采用特布他林、异丙托溴铵、普米克令舒联合雾化吸入治疗,比较两组治疗效果.结果:观察组有效率高于对照组,症状缓解时间少于对照组(P<0.05).结论:特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效显著.</abstract><pub>223700,江苏省宿迁市泗阳康达医院呼吸科</pub><doi>10.3969/j.issn.1007-614x.2018.32.032</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1007-614X |
| ispartof | 中国社区医师, 2018, Vol.34 (32), p.53-54 |
| issn | 1007-614X |
| language | chi |
| recordid | cdi_wanfang_journals_zgsqys201832032 |
| source | Alma/SFX Local Collection |
| title | 特布他林雾化液、异丙托溴铵雾化液、普米克令舒联合雾化吸入治疗慢阻肺急性加重期的疗效观察 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A13%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E7%89%B9%E5%B8%83%E4%BB%96%E6%9E%97%E9%9B%BE%E5%8C%96%E6%B6%B2%E3%80%81%E5%BC%82%E4%B8%99%E6%89%98%E6%BA%B4%E9%93%B5%E9%9B%BE%E5%8C%96%E6%B6%B2%E3%80%81%E6%99%AE%E7%B1%B3%E5%85%8B%E4%BB%A4%E8%88%92%E8%81%94%E5%90%88%E9%9B%BE%E5%8C%96%E5%90%B8%E5%85%A5%E6%B2%BB%E7%96%97%E6%85%A2%E9%98%BB%E8%82%BA%E6%80%A5%E6%80%A7%E5%8A%A0%E9%87%8D%E6%9C%9F%E7%9A%84%E7%96%97%E6%95%88%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%AD%E5%9B%BD%E7%A4%BE%E5%8C%BA%E5%8C%BB%E5%B8%88&rft.au=%E5%BC%A0%E5%87%A4%E7%A7%8B&rft.date=2018&rft.volume=34&rft.issue=32&rft.spage=53&rft.epage=54&rft.pages=53-54&rft.issn=1007-614X&rft_id=info:doi/10.3969/j.issn.1007-614x.2018.32.032&rft_dat=%3Cwanfang_jour%3Ezgsqys201832032%3C/wanfang_jour%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_wanfj_id=zgsqys201832032&rfr_iscdi=true |